A little-understood sleep disorder affects millions and has clear links to dementia – 4 questions answered
A little-known and poorly understood sleep disorder that occurs during the rapid eye movement, or REM, stage of…
More US adolescents are obese but fewer are trying to lose weight
A decade-long national survey reveals a troubling trend: more US teenagers are becoming obese as motivation to lose…
Patients who stop GLP-1 drugs often restart or try alternatives
A large real-world study shows that patients who stop popular GLP-1–based weight-loss drugs often return to treatment or…
Most Insomnia Meds Don’t Worsen Sleep Apnea
Summary: Treating insomnia when a patient also has Obstructive Sleep Apnea (OSA)—a condition known as COMISA—is a delicate…
Impurity in Some Compounded Tirzepatide ‘Potentially Dangerous,’ Eli Lilly Warns
Compounded versions of tirzepatide (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk to the public, Eli…
How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?
A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for obesity and diabetes, delivering powerful…
Tirzepatide shows dual benefits in sleep apnea trial improving metabolism and reducing inflammation
New clinical trial evidence suggests targeting both obesity and sleep-disordered breathing together may reshape cardiometabolic risk management in…